Literature DB >> 20952450

Development of an in vitro model to investigate joint ochronosis in alkaptonuria.

Laura Tinti1, Adam M Taylor, Annalisa Santucci, Brenda Wlodarski, Peter J Wilson, Jonathan C Jarvis, William D Fraser, John S Davidson, Lakshminarayan R Ranganath, James A Gallagher.   

Abstract

OBJECTIVES: Alkaptonuria (AKU) is a genetic disorder caused by lack of the enzyme responsible for breaking down homogentisic acid (HGA), an intermediate in tyrosine metabolism. HGA is deposited as a polymer, termed ochronotic pigment, in collagenous tissues. Pigmentation is progressive over many years, leading to CTDs including severe arthropathies. To investigate the mechanism of pigmentation and to determine how it leads to arthropathy, we aimed to develop an in vitro model of ochronosis.
METHODS: Osteosarcoma cell lines MG63, SaOS-2 and TE85 were cultured in medium containing HGA from 0.1 μM to 1 mM. Cultures were examined by light microscopy and transmission electron microscopy, and Schmorl's stain was used to detect pigment deposits in vitro, following the observation that this stain identifies ochronotic pigment in AKU tissues. The effects of HGA on cell growth and collagen synthesis were also determined.
RESULTS: There was a dose-related deposition of pigment in cells and associated matrix from 33 μM to 0.33 mM HGA. Pigmentation in vitro was much more rapid than in vivo, indicating that protective mechanisms exist in tissues in situ. Pigment deposition was dependent on the presence of cells and was observed at HGA concentrations that were not toxic. There was an inhibition of cell growth and a stimulation of type I collagen synthesis up to 0.33 mM HGA, but severe cell toxicity at 1 mM HGA.
CONCLUSION: We have developed an in vitro model of ochronosis that should contribute to understanding joint destruction in AKU and to the aetiology of OA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20952450     DOI: 10.1093/rheumatology/keq246

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  25 in total

1.  The Distribution of Ochronosis in Osteoarthritic Articular Cartilage in a Knee.

Authors:  Vincent W Vigorita; Paul D Marino; Paul A Lucas
Journal:  HSS J       Date:  2015-10-15

2.  A role for interleukins in ochronosis in a chondrocyte in vitro model of alkaptonuria.

Authors:  J B Mistry; D J Jackson; M Bukhari; A M Taylor
Journal:  Clin Rheumatol       Date:  2015-10-16       Impact factor: 2.980

3.  Nitisinone Arrests but Does Not Reverse Ochronosis in Alkaptonuric Mice.

Authors:  Craig M Keenan; Andrew J Preston; Hazel Sutherland; Peter J Wilson; Eftychia E Psarelli; Trevor F Cox; Lakshminarayan R Ranganath; Jonathan C Jarvis; James A Gallagher
Journal:  JIMD Rep       Date:  2015-05-05

4.  Identification of candidate drugs for the treatment of metastatic osteosarcoma through a subpathway analysis method.

Authors:  Xin Li; Ming-Lan Yan; Qian Yu
Journal:  Oncol Lett       Date:  2017-03-29       Impact factor: 2.967

Review 5.  Old treatments for new insights and strategies: proposed management in adults and children with alkaptonuria.

Authors:  Jean-Baptiste Arnoux; Kim-Hanh Le Quan Sang; Anais Brassier; Coraline Grisel; Aude Servais; Julien Wippf; Sandrine Dubois; Nicolas Sireau; Chantal Job-Deslandre; Lakshminarayan Ranganath; Pascale de Lonlay
Journal:  J Inherit Metab Dis       Date:  2015-04-10       Impact factor: 4.982

6.  Osteoarticular cells tolerate short-term exposure to nitisinone-implications in alkaptonuria.

Authors:  J B Mistry; D J Jackson; M Bukhari; A M Taylor
Journal:  Clin Rheumatol       Date:  2015-05-31       Impact factor: 2.980

7.  Ochronosis in a murine model of alkaptonuria is synonymous to that in the human condition.

Authors:  A M Taylor; A J Preston; N K Paulk; H Sutherland; C M Keenan; P J M Wilson; B Wlodarski; M Grompe; L R Ranganath; J A Gallagher; J C Jarvis
Journal:  Osteoarthritis Cartilage       Date:  2012-04-24       Impact factor: 6.576

8.  Analysis of Melanin-like Pigment Synthesized from Homogentisic Acid, with or without Tyrosine, and Its Implications in Alkaptonuria.

Authors:  Adam M Taylor; Koen P Vercruysse
Journal:  JIMD Rep       Date:  2016-12-10

Review 9.  Amyloidosis in alkaptonuria.

Authors:  Lia Millucci; Daniela Braconi; Giulia Bernardini; Pietro Lupetti; Josef Rovensky; Lakshminaryan Ranganath; Annalisa Santucci
Journal:  J Inherit Metab Dis       Date:  2015-04-14       Impact factor: 4.982

10.  Homogentisate 1,2 dioxygenase is expressed in brain: implications in alkaptonuria.

Authors:  Giulia Bernardini; Marcella Laschi; Michela Geminiani; Daniela Braconi; Elisa Vannuccini; Pietro Lupetti; Fabrizio Manetti; Lia Millucci; Annalisa Santucci
Journal:  J Inherit Metab Dis       Date:  2015-03-12       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.